Single anticoagulant blood thinner after stent in atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether taking a single “P2Y12 inhibitor” blood thinner (instead of multiple medicines) is safe and effective after you get a coronary stent. It’s for people with atrial fibrillation who need long-term blood thinning and have recently had a successful stent procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have atrial fibrillation or flutter and need long-term blood thinners you take by mouth (DOACs) for at least 12 months
- You had a successful heart stent procedure within the last 7 days, and there are no other planned lesions to treat
- You had no major complications right after the stent (no suspected heart-attack chest pain, stent clot, or new neurologic symptoms)
- You can sign a consent form, and you’re not planning certain heart rhythm procedures or staged stent procedures soon
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
This study looks at whether taking just one blood-thinning medicine (instead of two) after a stent procedure helps prevent future heart problems while lowering the risk of bleeding. It's for people who recently had a heart attack or unstable chest pain and had a stent placed.
Hear when a new Oral Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.